CK Life Sciences International Holdings Inc CKLSF
Trading Information
- Previous Close Price
- —
- Day Range
- $0.09–0.09
- 52-Week Range
- $0.09–0.09
- Bid/Ask
- $0.00 / $800.13
- Shares Outstanding
- 9.61B
- Market Cap
- $865.00M
- Volume/Avg
- 76,900 / 76,900
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 1.25
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
CK Life Sciences International Holdings Inc is an international life sciences company. It is engaged in research and development, manufacturing, commercialization, marketing and selling of health and agriculture-related products, as well as investment in a portfolio of vineyards, and various financial and investment products. Its pipeline includes Seviprotimut-L, TTX-MC138, Seviprotimut-L + TTX-MC138, TTX-RIGA, Halneuron, among others. Its segments include Agriculture-related, Nutraceutical, and Pharmaceuticals & Diagnostics R&D with the majority of the revenue deriving from Nutraceutical segment. Geographically it operates in Asia Pacific that derives the majority of the revenue and North America.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Value
- Total Number of Employees
- 1,920
- Website
- https://www.ck-lifesciences.com
Valuation
|
Metric
|
CKLSF
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 1.78 |
Price/Sales | 1.25 |
Price/Cash Flow | — |
Price/Earnings
CKLSF
Financial Strength
|
Metric
|
CKLSF
|
|---|---|
Quick Ratio | 0.46 |
Current Ratio | 0.87 |
Interest Coverage | 0.85 |
Quick Ratio
CKLSF
Profitability
|
Metric
|
CKLSF
|
|---|---|
Return on Assets (Normalized) | −3.80% |
Return on Equity (Normalized) | −11.79% |
Return on Invested Capital (Normalized) | −1.83% |
Return on Assets
CKLSF
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc
VRTX
| LOCK|FV!><#@ | LOCK|<<!# | $126B | |||
| Regeneron Pharmaceuticals Inc
REGN
| LOCK|&#NvhF^ | LOCK|y#p!B | $81B | |||
| argenx SE ADR
ARGX
| LOCK|&^VKKT | LOCK|>X | $55B | |||
| Royalty Pharma PLC Class A
RPRX
| LOCK|HxLpvn&< | LOCK|?^?@S | $50B | |||
| BeOne Medicines Ltd ADR
ONC
| LOCK|&Df&#j> | LOCK|>Z | $41B | |||
| Alnylam Pharmaceuticals Inc
ALNY
| LOCK|&hNw>G< | LOCK|T$&p | $29B | |||
| Incyte Corp
INCY
| LOCK|D#M!lHG | LOCK|Nx | $24B | |||
| Moderna Inc
MRNA
| LOCK|!^lp<^k | LOCK|g$ | $24B | |||
| BioNTech SE ADR
BNTX
| LOCK|RrSg<xq | LOCK|n^ | $24B | |||
| Jazz Pharmaceuticals PLC
JAZZ
| LOCK|K@$^!@! | LOCK|Jx | $17B |
United States